Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's… (NCT07524400) | Clinical Trial Compass
RecruitingNot Applicable
Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease
Spain100 participantsStarted 2026-05-10
Plain-language summary
A controlled, blinded, and randomized clinical study will be carried out in a large sample of people with Parkinson's disease, where the combined effects of physical exercise and transcranial direct curren stimlation (tDCS) on motor function will be evaluated.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Clinical diagnosis of idiopathic Parkinson's disease, established according to the UK Parkinson's Disease Society Brain Bank Criteria.
Ability to understand and comply with study procedures.
Stable antiparkinsonian medication regimen prior to study participation.
Exclusion Criteria:
Significant cognitive impairment, defined as a score \< 23 on the Mini-Mental State Examination (MMSE).
Below-average premorbid intelligence, defined as a score \< 40 on the Vocabulary subtest of the Wechsler Adult Intelligence Scale - Third Edition (WAIS-III).
Clinically significant depression, defined as a score \> 10 on the Geriatric Depression Scale (GDS-15).
Current treatment with cholinesterase inhibitors.
Presence of severe cardiovascular disease, including but not limited to:
Congestive heart failure
Ischemic heart disease
Cardiac pacemaker
Orthostatic hypotension
Uncontrolled diabetes mellitus.
History of stroke or traumatic brain injury.
History of seizure disorder or epilepsy.
Presence or prior implantation of a deep brain stimulation (DBS) device.
History of major orthopedic surgery that could interfere with motor performance or gait.
Presence of implanted electronic devices, including cardiac pacemakers, incompatible with study procedures.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Gait Speed at Preferred Speed
Timeframe: From enrollment to the end of treatment at 7 weeks
2
Step length at Preferred Speed
Timeframe: From enrollment to the end of treatment at 7 weeks
3
Cadence at Preferred Speed
Timeframe: From enrollment to the end of treatment at 7 weeks
4
Gait Speed at Maximal Speed
Timeframe: From enrollment to the end of treatment at 7 weeks
5
Step Length at Maximal Speed
Timeframe: From enrollment to the end of treatment at 7 weeks
6
Cadence at Maximal Speed
Timeframe: From enrollment to the end of treatment at 7 weeks
7
Timed Up and Go test performance
Timeframe: From enrollment to the end of treatment at 7 weeks